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Strains of animals with genetic defects in their immune system have greatly 
facilitated  our  understanding  of various  pathways  in  B  and  T  lymphocyte 
development. Only a limited number of mouse strains exist that express relatively 
well-defined genetically determined defects in B lymphocyte function. Particu- 
larly notable among these are CBA/N mice, which possess a defective X-linked 
gene, xid,  which interferes with the development of cells  that have the  Lyb5 
surface antigen.  Such  mice are  unable  to  respond  to  purified polysaccharide 
antigens (1, 2). We have recently shown that introduction of the nu/nu gene into 
mice with the xid defect further impairs their ability to respond to B cell stimulants 
(3). The resultant CBA/N nu/nu mouse shows an immune defect that is greater 
than would be predicted from the combined defect of the two parental strains. 
Investigations of immune responses using this strain of mouse suggested that the 
T  cells may play an important role in directing the maturation of Lyb5- B cells. 
Since it appeared that combinations of genetically defined immune defects can 
be expressed synergistically rather than additively, we were interested in inves- 
tigating the immune responses of mice that express the xid-determined  defect 
and possess a defective gene or genes found in the C3H mouse strain. 
We have previously reported (4)  that when (CBA/N  x  C3H/HeJ)F1  female 
mice, which are heterozygous for the xid gene (+/xid), are crossed to male C3H/ 
HeJ mice,  B  cells of half of the  male progeny were  unable  to  make in  vitro 
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immune responses to type 1 antigens and to B cell mitogens that could effectively 
stimulate cells of both CBA/N and C3H/HeJ type (4). Since similar results were 
obtained using C3H/HeN  mice as the breeding partners,  it appeared  that the 
LPSa-determined defect of the C3H/HeJ mice was not required to produce these 
synergistic defects. We have now established two inbred lines of mice that express 
this  synergistic  immunological defect  and  we  report  here  the  immunological 
features of these  mice.  These  strains possess  the xid  trait  on either the  C3H/ 
HeN  or  C3H/HeJ  backgrounds  and  are  designated  C3.CBA/N  and  C3J.xid, 
respectively. Spleen  cells from mice of both strains do not respond in vitro to 
any  B  cell  mitogen  we  have  examined,  including  lipopolysaccharide  (LPS), ~ 
Nocardia  water-soluble  mitogen  (NWSM),  and  antiimmunoglobulin  (anti-Ig) 
antibody conjugated to Sepharose beads.  Additionally, their in  vitro antibody 
response to the type 1 antigen trinitrophenyi-Brucella  abortus (TNP-BA) is either 
undetectable  or  10-100  times  lower  than  that  of cells  from  parental  strains. 
Responsiveness of spleen cells from these defective strains cannot be enhanced 
by a  T  cell factor-rich supernatant,  whereas responsiveness of cells from both 
C3H and CBA/N  strains can be enhanced.  F~  female mice resulting from the 
mating of C3.CBA/N and C3J.xid exhibit the same profound immunologic defect 
as their parents,  suggesting that the genetic  basis for their defects is identical 
and noncomplementary. 
Materials and Methods 
Mice.  C3J.xid mice were obtained from original crosses  of CBA/N (xid]xid) females 
(obtained from the  Division  of Research Services,  National Institutes of Health) with 
C3H/HeJ (+/Y) males (The Jackson Laboratory, Bar Harbor, ME). Fl females resulting 
from this cross, which are heterozygous at the xid locus (+/xid), were crossed to C3H/HeJ 
males. The male offspring of this cross were immunized with TNP-aminoethylcarbamyl- 
methyl-Ficoll (TNP-Ficoll) (20 ~g), and their sera were tested 5 d later for the presence 
of anti-TNP antibodies by hemagglutination of TNP-sheep erythrocytes (TNP-SE).  Mice 
that failed to produce anti-TNP antibody were judged to be xid/Y and were mated to 
C3H/HeJ females. Four additional cycles of this type were carried out. xid]Y males from 
the ninth backcross generation were mated to +/xid females from the eighth backcross 
generation. Male and female progeny from this cross that were unresponsive to TNP- 
Ficoll were mated to create an inbred strain. Tail skin from mice of the fifth intercross 
generation was grafted to C3H/HeJ, BALB/c, and CBA/N mice. The grafts were not 
rejected by C3H[HeJ mice over a 4-too period whereas BALB/c mice rejected grafts by 
day 10 and CBA]N mice rejected the grafts by day 21. C3.CBA/N mice were bred as 
follows: The xid gene was introduced into the C3H/HeN inbred mouse strain by repeated 
cycles of backcrossing. The initial cross consisted of mating a  CBA/N female, which is 
homozygous for the xid gene, to a C3H/HeN male. The female progeny from this mating 
were heterozygous for the xid gene and the males, hemizygous. One of the male offspring 
was backcrossed to a CBA/N female. The progeny from the backcross mating were either 
homozygous, in case  of the females, or hemizygous, for the males.  The second cycle 
consisted of mating a homozygous female, now designated as C3.CBA/N, to a C3H/HeN 
male. A  male offspring from this mating was backcrossed to his mother to produce a 
homozygous female that was bred to a C3H/HeN male. This procedure was repeated for 
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the subsequent cycles that currently continue. The N equivalents for the mice used in this 
study vary from 5 to 7. 
Antibody-dependent Cell-mediated Cytotoxicity.  Antiserum to chicken erythrocyte (CE) was 
prepared by injecting a  10% suspension of CE into New Zealand rabbits. A pool of sera 
from three rabbits was used that had a hemagglutinin titer of 1.6  ×  10  -4. CE target cells 
(107) were incubated for 1 h  at 37°C with  150 ~tCi of sodium-51chromate (5'Cr) (sp act 
264  mCi/mg) (New England  Nuclear Boston, MA) and washed three times before use. 
Spleen cells from C3J.xid,  C3H/HeJ, and CBA/N mice were used as effector cells. 2.5 × 
106 effector cells in  1 ml RPMI  1640 medium supplemented with  10% fetal calf serum 
(Flow Laboratories, Inc., McLean, VA) were mixed with 105 labeled CE in 0.1  ml of heat- 
inactivated rabbit anti-CE antiserum, diluted  1:3,200, and then incubated at 37 °C for 18 
h. Effector cells cultured with 5~Cr-labeled  CE in the presence of normal rabbit serum at 
the same dilution with 5~Cr-labeled  CE alone in the absence of serum served as controls. 
Total radioactivity was taken to be equivalent to the radioactivity released by incubating 
the target cells with  1% Triton X-100. The tubes were incubated in an upright position 
at 37°C in an atmosphere of 5% CO2. They were then centrifuged for 10 min at 160 g 
and the radioactivity of the supernatant was determined in a gamma counter. 
Cytotoxicity  was  expressed  as  percent  specific  release  of label  as  follows:  Percent 
cytotoxicity =  [(cpmAb -- cpmsR)/(cpmT -- CpmsR)] ×  100, where cpmAb is the counts in 
supernatant of the tubes with rabbit serum (normal or anti-CE), CpmsR is the spontaneous 
release of counts  in  the  control  tubes  with  nonimmune  serum, and  cpmT is  the  total 
radioactivity released by treatment with Triton X-100. 
Antigens,  Mitogens, and  T  Cell Factors.  TNP-Ficoll  and  TNP-BA  were  prepared  as 
previously described (5, 6). LPS from Escherichia coli 0111 :B4, prepared according to the 
Boivin procedure, was purchased from Difco Laboratories, Inc., Detroit, MI. Since this 
mitogen contains lipoprotein, it is able to stimulate proliferative and plaque-forming cell 
(PFC) responses by C3H/HeJ spleen cells. NWSM was prepared according to the technique 
of Clorbovn  et  al.  (7).  Concanavalin  A  (Con  A)  was  obtained  from  Pharmacia  Fine 
Chemicals, Piscataway, NJ. Polymerized flagellin (POL) from Staphylococcus adelaide and 
type III pneumococcal polysaccharide (SIII) were a gift from Dr. P. Baker, Laboratory of 
Microbial  Immunity, NIH. Supernatant  fluid  from the  EL4  thymoma line,  stimulated 
with phorbol myristic acetate (PMA), was collected as previously described (8). Goat anti- 
mouse  IgM  and  IgD antibodies  were  purified  and  conjugated  to  Sepharose beads as 
previously described (9,  10). 
In Vitro and In Vivo Responses to Type 1 and Type 2 Antigens and to B Cell Mitogens.  Spleen 
cells from control or experimental mice were cultured in flat-bottomed microtiter plates 
(Costar, Data Packaging, Cambridge, MA) at a density of 106 cells per 0.2 ml of modified 
Mishell-Dutton  medium together with TNP-Ficoll (5  ×  10  -4 ~g/ml) or TNP-BA (10 -3 
dilution of stock) (3).  Anti-TNP direct PFC responses were measured after 3 or 4 d  of 
culture by a modified Jerne hemolytic plaque assay with TNP-SE as the target cells. 
Proliferative responses were measured by culturing 5 ×  105 or 2.5 ×  105 spleen cells in 
microtiter wells  with LPS (50 ug/ml),  NWSM (50 #g/ml),  POL (100/~g/ml),  SIII (100 
S  ug/mi), or Con A (2 t~g/ml).  1 uCi of [ H]thymidine (sp act 20 Ci/mmole) was added on 
3  day 2 of the culture period and uptake of [ H]thymidine was determined 18 h later using 
a liquid scintillation spectrometer. 
Cell Separation Procedures.  Mice received injections of 0.04  ml of rabbit anti-mouse 
thymocyte antiserum (ATS) (Microbiological Associates, Walkersville, MD).  48 h  later, 
spleen cell suspensions were prepared and treated with monoclonal anti-mouse Thy-l.2 
(Becton, Dickinson & Co.,  Sunnyvale, CA) and guinea pig complement and then resus- 
pended to  107 cells/ml in RPMI supplemented with  10%  FCS. 5.0 ml of these cells,  at 
107/ml, were incubated for an additional  1 h at room temperature on petri dishes coated 
with goat anti-mouse Ig antibody; adherent cells were recovered by detachment with a 
rubber policeman. Nonadherent cells (null cells) were found to contain <2% surface Ig 
(sIg)  ÷ or Thy-l.2  ÷ cells,  as evaluated by analysis of cells stained with fluorescein isothio- 
cyanate  (FITC)-Iabeled  monoclonal  anti-IgM  antibody  or  FITC-labeled  anti-Thy-l.2 
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For in vivo immunization, 0.1  ml of a  1:10 dilution of TNP-BA was injected intrave- 
nously and anti-TNP PFC responses measured 5 and 7 d later. Sera was assayed for anti- 
T NP antibody using a radioimmunoassay as previously described (11). 
Flow Microfluorometric Analysis of slg + Cells.  FITC conjugates of F(ab')2 fragments of 
rabbit anti-mouse  IgM, goat anti-mouse  IgD, and goat anti-keyhole limpet  hemocyanin 
(KLH) were prepared  as previously described  (10).  FITC-conjugated anti-Thy-l.2  was 
prepared using a monoclonal anti-Thy-l.2 (Becton, Dickinson & Co.). Preparation of cells 
for staining and the method for their analysis on the FACS II (B-D FACS Systems, Becton, 
Dickinson & Co.) has been previously described (10). 
Results 
In  Vitro  Antibody  Responses  of C3J.xid  and  C3.CBA/N  to  TNP-BA  and  TNP- 
Ficoll.  We  have  recently  proposed  that  antigens  be  classified  on  the  basis  of 
their ability to stimulate antibody responses in nu/nu and xid mice (12,  13). Type 
1 antigens,  which include TNP  conjugates ofB. abortus, LPS, and NWSM, have 
TABLE  I 
h~ Vitro Response of Spleen Cells Obtained from C3.xid or C3.CBA/N 
to TNP-BA 
Experiment No.  Mouse strain (number of  mice)  Anti-TNP PFC/culture 
1  CBA/N (3)  164 (1.14) 
C3H/HeN (3)  298 (1.21) 
C3.CBA/N (3)  0 
CBA/N (I)  251 (1.02) 
C3H/HeN (I)  471 (1.28) 
C3.CBA/N 
No. 1  2O (1.05) 
No. 2  40 (1.11) 
No. 3  0 
No. 4  34 (1.41) 
No. 5  20 (2.43) 
No. 6  10 (1.10) 
CBA/N (2)  166 (1.20) 
C3.CBA/N (5)  6 (1.52) 
CBA/N (2)  I00 (1.24) 
C3H/HeJ (2)  398 (1.31) 
C3J.xid 
No. 1  0 
No. 2  0 
No. 3  0 
No. 4  0 
l0  s spleen  cells from normal or immune-defective  mice were  cultured 
with TNP-BA, and anti-TNP PFC were assayed on day 3 or 4 of culture. 
Results represent geometric mean of triplicate  wells (x/+  mean SE). In 
experiments  1 and  3, cells were pooled from groups of mice (number 
indicated  in parenthesis) and pooled cells were cultured. In experiment 2, 
cells from individual mice were cultured. In experiment 4, pools of CBA/ 
N and C3H cells were cultured; cells from individual C3J.xid mice were 
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TABLE  II 
Addition of C3J.xid Spleen Cells to C3H Spleen Cells Does Not 
Suppress the In Vitro Response  to TNP-BA 
Anti-TNP PFC/cuhure 
Cells in culture 
Exp.  1  Exp. 2  Exp. 3 
C3H  506 (1.25)  74 (1.34)  56 (1.11) 
C3J.xid  9  0  0 
C3H +  C3J.xid  798 (1.23)  210 (1.27)  94 (1.14) 
C3H cells were cultured at 10  6, 5  x  l0  s, or 4  X  l0  B cells/well in experi- 
ments 1-3, respectively, together with 5 x  l0  B  C3J.xid cells and TNP-BA. 
3 d later anti-TNP PFC were determined. Results represent the geometric 
mean (x/+ mean SE) of triplicate cultures. 
been shown to stimulate in vitro and in vivo responses by nu/nu mice and by 
CBA/N xid mice. Type 2 antigens, represented by soluble polysaccharides and 
their hapten conjugates, stimulate responses in nu/nu mice but not in CBA/N 
mice. While spleen cells from C3H/HeN, C3H/HeJ, and CBA/N mice respond 
to the type 1 antigen TNP-BA, splenic B cells from the two inbred lines described 
here, C3.CBA/N and C3J.xid, were either poorly responsive or unresponsive to 
both  antigens  (Table  I).  This  low  level of responsiveness was  seen at all  cell 
densities tested varying from 2.5 x  105 to 106 per well (data not shown). 
The impaired responsiveness of cells from the C3J.xid mice does not appear 
to be a consequence of the presence of naturally occurring suppressor cells, since 
equal mixtures of these nonresponder spleen cells with C3H spleen cells did not 
suppress the antibody response to TNP-BA mounted by the normal spleen cell 
population (Table II). In other experiments, removal of T  cells from the C3J.xid 
spleen cell population did not lead to increased responsiveness of their B cells to 
TNP-BA, further suggesting that a T  cell suppressor population was not influ- 
encing their lack of responsiveness to TNP-BA. Addition of T  cells from C3H/ 
HeN mice to cultures of spleen cells from C3.CBA/N also did not influence their 
responsiveness to TNP-BA (data not shown). 
mitogen Responsiveness of Cells  from C3.CBA/N and C3J.xid Mice.  In vitro pro- 
liferative responses to the B cell mitogens LPS and NWSM,  which previously 
have been shown to stimulate responses by B cells of CBA/N,  C3H/HeJ,  and 
C3H/HeN mice, were evaluated in spleen cell cultures of C3.CBA/N and C3J.xid 
mice.  In  the experiments reported here these mitogens stimulated substantial 
proliferation by spleen  cells from control C3H/HeN,  C3H/HeJ,  and  CBA/N 
mice as evaluated by incorporation of [3H]thymidine. LPS and NWSM had either 
minimal or no stimulatory effect on spleen cells from C3.CBA/N  and C3J.xid 
mice (Table III). To evaluate whether the occasional meager responses stimulated 
by NWSM reflected stimulation to the Ig  + cell population of C3J.xid mice, the 
responses of unseparated spleen cell populations were compared with those of 
purified sIg  + cells or of sIg- Thy-l.2- cells at various cell concentrations. The 
modest response of C3J.xid spleen cells to NWSM appeared to be almost com- 
pletely accounted for by the proliferative responses mounted by the null  cell 
population.  The purified B cell population of these mice was essentially unres- 
ponsive to this mitogen (Fig.  1).  Previous studies using rabbit lymphocytes also 1406  C3.CBA/N  UNRESPONSIVE TO  B CELL MITOGENS, T  CELL FACTORS 
TABLE III 
In Vitro Proliferative Response of C3.CBA/N and C3J.xid to B and T Cell Mitogens 
Strain (number of  Exp.  mice)  Medium  LPS (Boivin)  NWSM  Con A 
cpm 
C3H/HeN (3)  5,293  29,332  16,606  78,242 
CBA/N (3)  5,401  44,482  29,880  60,135 
C3.CBA/N (3)  1,652  3,849  4,896  90,438 
C3H/HeN (1)  8,337  24,910  98,217 
CBA/N (1)  422  41,364  180,295 
C3.CBA/N 
No. 1  2,299  3,965  152,295 
No. 2  2,130  4,125  155,428 
No. 3  1,381  3,716  65,581 
No. 4  2,799  4,319  137,478 
No. 5  1,636  3,432  141,295 
No. 6  2,237  3,085  129,195 
C3H/H~ 
No. 1  823  27,062 
No. 2  371  20,932 
No. 3  215  7,151 
CBA/N 
No. 1  98  33,214 
No. 2  82  18,977 
No. 3  99  12,117 
C3J.xid 
No. 1  127  925 
No. 2  123  1,348 
No. 3  227  2,794 
Spleen cells from C3H/HeN, C3H/HeJ, CBA/N, C3J.xid, and C3.CBA/N were cultured 
at 5 × 105 cells/well in modified Mishell-Dutton medium with 50 #g/ml of LPS, 10 ug/ 
ml of NWSM, and 2 ug/ml of Con A for 3 d.  18 h before harvest, cells were pulsed 
with 1.0 Ci of [SH]thymidine. Results represent arithmetic mean _ SE of triplicate wells. 
In experiment 1, cells were pooled from groups of three mice. In experiments 2 and 3, 
cells from individual mice were cultured. 
had  suggested that  NWSM  could induce an  increase  in  incorporation of [~H]- 
thymidine in populations of Ig- RTLA-Fc receptor (FcR)  + cells (14). 
Soluble  anti-IgM  and  anti-IgD  antibodies  do  not  stimulate  proliferation  in 
spleen cells from mice with the xid defect (15). However, we have recently shown 
that anti-Ig antibodies conjugated to Sepharose beads  can stimulate  significant 
proliferation  in cells from such mice (16).  In marked contrast, however, spleen 
cells from C3.CBA/N mice are only marginally stimulated  in response to anti- 
IgM or anti-IgD conjugated to Sepharose beads (Table IV). 
Inability of T  Cell-derived  Factors to Enhance  Responsiveness  of C3.CBA/N  Spleen 
Cells to TNP-BA.  We have previously shown that in vitro PFC responses to the 
type  1  antigen  TNP-BA can  be  enhanced  by  the  addition  of various  T  cell- 
derived lymphokines, including factors found in supernatants derived from PMA- 6000 
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TABLE  IV 
Impaired Proliferative Response of C3. CBA/N Spleen Cells to Anti-lg Conjugated to Sepharose Beads 
Exp.  Cell source  Medium  Antiferritin bead  Anti-# bead  Anti~ bead  LPS  Con A 
No. 
¢ptn 
1  C3H/HeN  3,959 ±  425  4,965 :t: 180  23,246 3= 1,892  48,164 4. 3,763  30,908 4- 1,277 
CBA/N  6,732 4. 92  8,734 =1:930  25,959 4. 1,515  46,035 4. 1,587  22,262 4. 2,672 
C3.CBA/N  2,210:1:180  2,229 4. 82  3,482 4- 52  3,047 4- 511  3,743 4- 601 
2  C3H/HeN  2,164 4- 138  2,946 =1:192  21,605 4- 892  ND  25,223 4. 2,999 
CBA/N  7,459 4. 569  10,491  4. 1,079  43,107 4. 2,887  52,884 4. 4,505  54,616 4- 791 
C3.CBA/N  3,192 =t= 267  4,534 4- 369  9,959 4. 892  10,002 4. 478  7,211 =1:452 
96,648 4- 5,034 
85,755 4. 7,096 
85,964 4. 4,375 
5  x  l0  s spleen  cells  from C3H/HeN,  CBA/N, or C3.CBA/N  were cultured  in flat-bottomed  microtiter wells  in  modified Mishell-Dutton 
medium. The concentration  of B cell stimulators used was: LPS, 50 #g/ml; anti-lg beads at a  1:20 dilution of stock material; Con A at 2 tag/ 
m l. After 2 d of culture,  1.0 Ci of [SH]thymidine was added and cells were harvested 18 h later.  Results represent arithmetic mean 4- SE of 
triplicate wells. 
stimulated  EL4  thymoma cell  line  (17).  To  determine whether the impaired 
responses of C3.CBA/N  to  TNP-BA could be enhanced by soluble factors in 
such supernatants,  we cultured their splenic  B  cells with  TNP-BA  and  EL4- 
derived supernatant (Table V).  Although this factor markedly enhanced PFC 
responsiveness of cells from CBA/N and C3H/HeN mice to type 1 antigens, it 
had little or no effect on C3.CBA/N cells. 
Flow Microfluorometric Analysis of slg + Cells in the Spleen, Lymph Node, and Peyer's 
Patch of C3.CBA/N mice.  To examine whether the reduced responsiveness of 
spleen cells obtained from C3.CBA/N mice reflected a reduced number of slg  ÷ 
cells in their lymphoid organs we stained their cells with FITC-conjugated anti- 
#,  anti-6,  or  anti-Ia  antibodies  and  enumerated the  percentage  of positively 
stained cells using the FACS (Table VI). Their spleens had on the average 30% 
fewer slgM ÷ cells as compared with CBA/N  mice, and 60%  fewer than  C3H 1408  C3.CBA/N  UNRESPONSIVE TO  B CELL  MITOGENS,  T  CELL  FACTORS 
TABLE  V 
Inability of C3.CBA/N B Cells to Respond to T Cell-derived Factors in EL4 Supernatant 
Anti-TNP PFC/culture 
Exp. No.  Source of cells  Me-  TNP-  TNP-BA + 
EL4 super-  dium  BA  natant 
EL4 
1  CBA/N  0  142 (1.08)  814 (1.16)  24 (1.18) 
C3.CBA/N  0  0 (1.12)  12 (1.26)  0 
C3H/HeN  16 (1.49)  148 (1.25)  746 (1.03)  36 (1.52) 
CBA/N  4 (1.44)  28 (1.42)  672 (1.38)  20 (1.33) 
C3.CBA/N  4 (1.26)  14 (1.48)  34 (1.42)  0 
106 spleen cells from CBA/N, C3.CBA/N, or C3H mice were cultured with TNP-BA in the presence 
or absence  of 10% EL4 supernatant material.  3 d later,  cells were harvested  and anti-TNP PFC 
determined. Results represent geometric mean (x/+ mean SE) of triplicate cultures. 
TABLE  VI 
FACS Analysis of sIgM ÷, slgD ÷, sla +, and Thy-l.2 + Cells Obtained  from C3.CBA/ 
N or from Control Mice 
Cell source 
Percent of positive cells 
slgM ÷  slgD  +  sla  +  Thy-1.2  ÷ 
Spleen  C3H/HeN  51.9  43.2  55.2  40.5 
CBA/N  35.4  27.5  39.3  57.4 
C3.CBA/N  21.9  11.5  27.5  32.5 
C3.CBA/N  23.2  11.9  27,6  32.9 
Lymph node  C3H/HeN  20.9  23.5  26.8  87.5 
CBA/N  14.4  13.6  19.2  87.3 
C3.CBA/N  2.7  2.8  5.3  84.5 
C3.CBA/N  4.0  3.6  7.4  87.6 
Peyer's patch  C3H/HeN  30.4  34.6  64.7  40.4 
CBA/N  27.5  24.8  42.9  61.6 
C3.CBA/N  18.0  13.8  15.8  42.1 
C3.CBA/N  16.7  14.1  41.0  44.4 
Cells were obtained from spleen,  popliteal  lymph node, or Peyer's patch and stained 
with FITC-conjugated antibodies  and analyzed on the FACS as described  in Materials 
and Methods. Cells from two individual mice were pooled in each group. 
mice; their  Peyer's patch had 40% fewer slgM ÷ cells than either parental  strain, 
and  their  lymph  nodes  had  80-90%  fewer  IgM  ÷ cells than  the  control  strains. 
An additional  striking  difference  was  noted  in  the  increase  in  the  numbers  of 
sIgM  ÷  spleen  cells  that  lacked  detectable  sIgD.  On  the  average,  75-80%  of 
sIgM  + splenic B cells from CBA/N  mice express sIgD, whereas, of sIgM  ÷ splenic 
cells from C3.CBA/N,  only 40-50%  express sIgD and the median  fluorescence 
intensity of these sIgD  ÷ cells is significantly lower than that of control cells (data 
not shown); the sIgM  + cells obtained from Peyer's patches or lymph nodes from 
C3.CBA/N  mice were of a  more mature phenotype and expressed  sIgD as well. 
The  fact that the  numbers  of Thy-l.2 + cells in the  spleens  of C3.CBA/N  mice 
was not increased above that found in the spleens  of control mice reflected the MOND  ET  AL. 
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Cell source  Antigen 
Direct PFC/106  Facilitated PFC/106 
Day 5  Day 7  Day 5  Day 7 
C3H/HeN  TNP-BA  187 (1.18)  137 (1.08)  84 (1.02)  53 (1.03) 
CBA/N  TNP-BA  71 (1.42)  29 (1.22)  10 (2.29)  11 (1.46) 
C3.CBA/N  TNP-BA  148 (1.14)  40 (1.28)  26 (1.12)  22 (1.74) 
C3H/HeN  TNP-FicolI*  485  225  229  533 
CBA/N  TNP-Ficoll  10  10  10  10 
C3.CBA/N  TNP-Ficoll  10  10  10  10 
Mice were immunized (four per group) intravenously with 0.1  ml of TNP-BA or 50 g of TNP- 
Ficoll.  5 or 7 d  later,  spleen cells of individual mice were evaluated  for numbers  of direct  or 
facilitated anti-TNP PFC. 
* For evaluation of PFC responses to TNP-FicoI1, a pool of spleen cells from two C3H/HeN mice 
was used. 
TABLE  VIII 
Reciprocal of IgM Anti-TNP Titer in Serum Obtained  from Mice 
Injected with TNP-BA 
IgM anti-TNP antibody titer 
Mouse strain 
Day 5  Day 7 
C3.CBA/N  22,115 (1.17)  17,552 (1.22) 
CBA/N  24,852 (1.44)  25,399 (1.61) 
C3H/HeN  108,664 (1.32)  90,903 (1.15) 
Mice (three  per group) were immunized intravenously with 0.1  ml of a 
1:10 dilution of stock TNP-BA and sera were collected 5 and 7 d later. 
Preimmune anti-TNP titers were 204 (1.85) and 1,102 (2.90) for C3.CBA/ 
N and CBA/N mice, respectively. 
presence of an increase in the percentage of Thy-1.2- slg- cells in these mice. 
Responsiveness  of C3. CBA/N Mice to In Vivo Challenge  with TNP-BA.  To investi- 
gate the immune potential of C3.CBA/N mice to in vivo challenge with antigens, 
we immunized them with type 1 antigen TNP-BA and type 2 antigen TNP-Ficoll 
(Table  VII).  As  expected,  the  mice  with  the  xid  defect  were  unresponsive  to 
TNP-Ficoll;  however,  all  three  strains  responded  to  immunization  with  TNP- 
BA.  The  facilitated  PFC  response  of both  CBA/N  and  C3.CBA/N  was  lower 
than that of C3H mice. In another experiment,  C3H, C3.CBA/N,  and CBA/N 
mice  were  immunized  intravenously  with  TNP-BA,  and  serum  titers  of anti- 
TNP  antibody  were  determined  (Table  VIII).  No  significant  difference  was 
observed  in  the  IgM  anti-TNP  antibody  response  between  the  CBA/N  and 
C3.CBA/N. 
Antibody-dependent Cell-mediated  Cytoxicity of Spleen  Cells from C3J.xid Mice.  The 
level of antibody-dependent  cell-mediated cytotoxicity that  reflects the activity 
of the  Ig- Thy-l.2-  spleen cells was compared in spleen cells from C3J.xid and 
parental strain mice. Spleen cells were cultured  (106,  2.5  ×  106,  and 5  ×  105)  in 
the presence of l0 s 51Cr-labeled CE at a  dilution  of 1:3,200  rabbit anti-CE.  At 
all  effector/target cell  ratios  tested,  there  was a  significant  increase of specific 1410  C3.CBA/N  UNRESPONSIVE  TO  B  CELL  MITOGENS,  T  CELL  FACTORS 
70%r 
6O°h 
~ 
50% 
40% 
20%~  j 
lx  106  2.5× 106  5x 10  s 
NUMBER OF EFFECTOR CELLS 
FIGURE 2. 
TABLE  IX 
Lack of Complementation of the B Cell Immune Defect in an F] Female Mouse Obtained  from the 
Mating of C3J.xid and C3.CBA/N 
Anti-TNP PFC re-  Proliferative response to" 
Strain 
sponse to TNP-BA  Medium  LPS 
fp~// 
C3H/HeN  438 (1.03)  2,045 -  236  49,228 +  3,746 
CBA/N  428 (1.15)  824 +  32  38,149 +  3,683 
C3J.xid  94 (1.17)  2,177 +  222  3,493 +  468 
(C3J.xid × C3.CBA/N)FI 
No.  1  48 (1.05)  1,363 --- 147  4,083 +_ 2,720 
No. 2  54 (1.09)  2,083 _  270  5,142 _  3,059 
No. 3  0  2,685 -  91  6,293 +  3,608 
Spleen cells from mice were cultured at 106/well  for evaluation of in vitro anti-TNP PFC responses 
to TNP-BA, and harvested 3 d later. For evaluation of the proliferative response to LPS (50 ug/ml), 
cells were cultured at 5 ×  105/well  and harvested on day 3 of culture, following an 18-h pulse with 
[SH]thymidine. In data not presented, culturing of these cells at 2.5  ×  105/well  or harvesting 1 d 
earlier did not show any significant difference from that reported in the table. Results of proliferative 
responses to LPS and medium represent the arithmetic mean +  SE of triplicate wells.  Pools of two 
CBA/N, C3J.xid, and C3H/HeN were used. Results for anti-TNP PFC represent geometric mean 
(x/+ mean SE). 
5]Cr release when cells from C3J.xid mice were used as compared with cells from 
C3H/HeN  or  CBA/N  strains  (Fig.  2).  These  results  are  consistent with  the 
increased numbers of Thy-l.2- sIg- cells found in these mice. 
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from the Mating of C3.CBA/N and C3J.xid.  To determine whether the genetic 
basis for the immune defects of the C3.CBA/N and C3J.xid were similar, female 
progeny of a cross of these two strains were studied (Table IX). Both the in vitro 
proliferative response stimulated by LPS and the in vitro antibody response to 
TNP-BA was impaired in the cells from these mice, suggesting that the immune 
defects of these two strains of mice reflect a common genetic derangement. It 
should be  noted, however, that  since individual cells express only a  single X 
chromosome, F1 females should actually be chimeras of C3.CBA/N and C3J.xid 
B  cells.  The  fact that  such  F~  females have a  defect similar to  both  parents 
suggests that the functions of their B cells do not complement one another. The 
result  does  not  formally demonstrate  that  the  genetic  defects are  identical. 
However, since both strains are derived by placing the CBA/N X  chromosome 
(xid) on a C3H background, it seems likely that their defects would be the same. 
Discussion 
The introduction of the xid gene onto the C3H background leads to a profound 
B cell immunodeficiency  characterized by in vitro B lymphocyte  unresponsiveness 
to both type 1 and 2 antigens as well as to a series of B cell mitogens including 
LPS, NWSM, and anti-Ig antibody conjugated to Sepharose beads. These defects 
appear to be intrinsic to B cells since (a) the addition of C3H/HeN T  cells and 
macrophages to C3.CBA/N spleen cells does not allow a response to occur, and 
(b)  spleen  cells from C3.CBA/N  mice do  not  suppress  antibody responses of 
C3H/HeN  spleen cells.  Our results showing that the introduction of xid into 
either C3H/HeN  or C3H/HeJ mice leads to comparable deficits indicates that 
the LPS  a gene is not critical for this synergistic defect. Furthermore, introduction 
of the xid gene into a  different LPSd-bearing  strain,  C57BL10/ScN,  does not 
result in unresponsiveness to either TNP-BA or to Boivin preparations of LPS 
(unpublished observations). 
Mice of the C3.CBA/N strain do mount in vivo anti-TNP responses to TNP- 
BA that are comparable in  magnitude to  that of CBA/N  mice, and in recent 
studies we have shown that C3J.xid mice mount normal primary and secondary 
in  vivo  antibody  responses  to  TNP-KLH  and  to  the  hemagglutinin  of PR8 
influenza virus (unpublished observations). Thus, the synergistic defect, although 
profound, does not preclude antibody responsiveness in general. 
The in  vitro  unresponsiveness of these mice obviously does not reflect the 
absence of B  cells.  Although  this  is  implicit  in  their  ability  to  make in  vivo 
responses to TNP-BA and PR8,  it is directly established by studies of their B 
cells. The percent of sIgM  + cells in spleens and Peyer's patches of C3.CBA/N 
mice is "-,30% less than that of CBA/N mice and "-60% less than that of C3H/ 
HeN mice; a greater decrease in the percent of sIgM  + cells was observed in the 
peripheral  lymph  nodes  of these  immune-defective mice.  It  is  of particular 
interest that the frequency of sIgD  + cells in  the spleen of C3.CBA/N  mice is 
markedly reduced, to 50% of the number of sIgM  + cells. The high frequency of 
sIgM  + sIgD- cells in these mice could reflect either the relatively large numbers 
of immature B cells or the presence of activated B cells that have lost sIgD. Since 
lymph nodes normally contain large numbers of activated B  lymphocytes but 
have few immature B lymphocytes, the paucity of sIg  + cells in lymph nodes from 1412  C3.CBA/N  UNRESPONSIVE  TO  B  CELL  MITOGENS,  T  CELL  FACTORS 
C3.CBA/N  mice suggests that the sIgM  + sIgD- spleen cells represent a largely 
immature rather than an activated population of B cells. 
The  inability of cells  from  C3.CBA/N  mice to  respond  in  vitro  to  type  1 
antigens or to B cell mitogens may be a  result of their inability to respond to 
various lymphokines that influence B cell growth, such as those present in EL4 
supernatant. This suggestion is premised on the idea that for in vitro responses 
to type 1 and 2 antigens and to B cell mitogens, including insolubilized anti-Ig, 
it is not antigen-specific T  cells that influence the magnitude of the response but 
rather T  cell-derived lymphokines that are required to enhance B cell respon- 
siveness. B.  abortus functions in vitro as a  type  1 antigen, but it also has been 
shown to stimulate antigen-specific T  cells in vivo (18). Thus, it is not surprising 
that in vivo immunization of normal mice with TNP-BA can stimulate responses 
dependent on carrier-specific T  cells as well as factor-dependent responses. Our 
observation  that  C3.CBA/N  and  C3J.xid  mice respond in  vivo to  the T  cell- 
dependant antigen TNP-KLH suggests that the pathway dependent on carrier- 
specific T  cells is intact in these animals. We propose that the in vivo response 
of C3.CBA/N mice to TNP-BA results from the action of carrier-specific T cells. 
Based on these observations, we propose the following model (Fig. 3) to explain 
the "synergistic defect" of C3.CBA/N  and C3J.xid  mice: C3H/HeN and C3H/ 
HeJ mice may have an immune defect in  B cell function that is not normally 
detected but which in an xid mouse has a profound effect on the overall B cell 
response. Such mice with the xid defect lack a  mature subset of Lyb5  ÷ B cells 
and have only Lyb5- B cells that can be activated by antigens via two alternative 
routes, that involving carrier-specific T  cells and that involving type 1 antigens 
(e.g., TNP-BA, LPS) and soluble factors. In vitro, where carrier-specific T  cell 
help is limiting, stimulation of resting Lyb5- B cells with a combination of type 
1 antigen and lymphokines leads to B cell proliferation and differentiation. Since 
B cells from C3.CBA/N mice, however, are poorly responsive to type 1 antigens 
and to factors in  EL4 supernatant, it would be reasonable to propose that the 
defect of these mice lies in the insensitivity of their Lyb5- B cells to stimulation 
along that pathway of activation that is available to "normal" Lyb5- cells. 
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FIGURE 3. 
The pathway of factor-dependent activation of resting Lyb5- cells by type 1 
antigens cannot be initiated by T  cell-dependent antigens in a primary in vitro 
antibody  response  since  responsiveness  to  this  class  of antigens  requires  the 
participation of a number of T  cell-derived lymphokines to which Lyb5- B cells 
from  CBA/N  mice are  unable  to  respond  (19,  20).  The  second pathway  of 
activation that is available to Lyb5- B cells proceeds via interaction with a carrier- 
specific, major histocompatibility complex (MHC)-restricted T  helper cell. This 
mode of activation stimulates Lyb5- cells from CBA/N  mice as well as from MOND ET  AL.  1413 
C3.CBA/N and C3J.xid.  Thus, in vivo, where carrier-specific T  cells are in less 
limiting numbers than in vitro, B cells of C3.CBA/N mice can be stimulated to 
antibody production by either T  cell-dependent antigens or by a number of type 
1 antigens that can also function as T  ceil-dependent antigens and thus are able 
to stimulate carrier-specific T  cells.  The C3J.xid and C3.CBA/N strains of mice 
therefore appear  to be entirely limited in their B cell responses to the use of 
cognate interaction involving the interactions of carrier-specific T  cells  with B 
cells. This should provide an excellent model for the examination of such B cell 
activation in in vivo and in vitro immune responses. 
Summary 
Introduction of the CBA/N X-linked gene into C3H mice has resulted in the 
establishment of a new strain of mice that has profound immunologic defects. B 
cells from these mice show significantly impaired in vitro immune responses to 
the T  cell-independent type 1 antigen trinitrophenyl-Brucella  abortus (TNP-BA) 
as well as markedly reduced proliferative responses to a number of  B cell mitogens 
when compared with the responses of the parental control mice.  The in vivo 
response of such mice to TNP-BA is, however, comparable to that of CBA/N 
mice. Furthermore, B cells from C3.CBA/N mice are unresponsive to the plaque- 
forming  cell  enhancing  effects  induced  by  EL4-derived  supernatant  in  the 
presence of TNP-BA, unlike B cells obtained from CBA/N or C3H/Hen mice 
whose responsiveness to TNP-BA can be significantly enhanced in the presence 
of EL4-derived supernatant. The model we have presented to best explain these 
results suggests that B cells from C3.CBA/N mice can be stimulated only under 
conditions in which they can interact with carrier-specific T  cell help and not 
under conditions where factor-dependent responses are dominant. 
Received for publication 1 June 1983. 
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